Navigation Links
Sale of Colon Cancer Diagnostic Tool to Czech Republic
Date:4/30/2008

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has sold one of its WavSTAT(R) Optical Biopsy Systems to the Almeda Company of Prague, Czech Republic. The device will be used at the University of Prague during colonoscopy to determine if tissue is normal, pre-cancerous or cancer.

Generally, doctors search for polyps, which are abnormal growths that stick out from the colon lining and can turn into cancer. However, another type of growth is much more dangerous and harder to see because it is flat or depressed and similar in color to healthy tissue. The WavSTAT uses an optical probe in conjunction with a colonoscope to determine within seconds if these flat or depressed lesions are cancerous or pre-cancer with greater than 96% accuracy.

Michel Vaudry, SpectraScience's Director of International Sales said, "The Czech Republic has one of the highest instances of colorectal cancer in the world. Our Czech partner, the Almeda Company, sees a large opportunity in helping physicians detect these flat 'polyps' at an early stage. In a recent study, it was found that close to 10% of patients had flat lesions, and that these lesions were five times as likely as polyps to contain cancerous or precancerous tissue. The flat or depressed lesions accounted for 15 percent of the potentially cancerous growths found in the study, but were involved in half of the cancers."

Vaudry continued, "The feeling amongst physicians that we have spoken with in the Czech Republic is that the WavSTAT is a wonderful adjunctive tool to aid in early detection of these flat lesions. We are now exploring additions to our export team in other European countries such as Italy, Germany and France."

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Ex
'/>"/>

SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation
2. Colon Cancer Screening Laws Now Cover Half of U.S. Population
3. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
4. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
5. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
6. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
7. Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research
8. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
9. One4One Campaign to Raise $1 Million to Improve Cervical Cancer Education and Resources
10. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
11. Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Proove ... medicine, will be exhibiting data and research conducted through ... International Spine Intervention Society’s (ISIS) 22nd Annual Scientific ... at the Hyatt Regency, in Orlando, Florida. ... and clinical competence of physicians who care for patients ...
(Date:7/28/2014)... 2014 Immunomic Therapeutics, Inc. (ITI) has ... develop potential treatments for glioblastoma multiforme (GBM), the most ... their patented vaccine platform, LAMP-vax. , The agreements, ... on the work of John H. Sampson, MD, PhD, ... Robert Tisch Brain Tumor Center at Duke University Medical ...
(Date:7/28/2014)... 2014  InterMune, Inc. (NASDAQ: ITMN ) ... 2014 financial results at the close of the U.S. ... and webcast will be hosted by InterMune at 4:30 ... investors and others may participate in the conference call ... ID#21728775. A replay of the webcast and teleconference will be ...
(Date:7/25/2014)... July 26, 2014 "Ischemic Stroke ... 2014" provides data on the Ischemic Stroke and ... elemental information and data relating to the clinical ... View full global Ischemic Stroke Research Report 2014 ... overview of the trial numbers and their recruitment ...
Breaking Biology Technology:Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced ... three-month period ended September,30, 2008. The Company will host ... time (details follow below). , ... million,an increase of 18% from fiscal 2007 revenues of $66.1 ...
... Biochemistry and,Genetics boasted top marks this evening for James ... in the Region Six Finals of the 2008,Siemens Competition ... science competition. , ... Foundation, is,administered by the College Board. Tonight,s winners will ...
... BSX ) is scheduled to participate in the Piper ... 3 in New York City. , Jim Tobin, ... 2, beginning at approximately 8:00 a.m. E.T. , ... remarks will be available to all interested,parties at Boston Scientific,s ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nation's Premier High School Science Competition 2Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nation's Premier High School Science Competition 3Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nation's Premier High School Science Competition 4Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nation's Premier High School Science Competition 5Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nation's Premier High School Science Competition 6
(Date:7/28/2014)... The findings of a new study suggest two ways ... not work as well in obese women, compared to women ... are a one-size-fits-all method, researchers say, but as the population ... the pill works for obese women. Studies have consistently found ... the body, which may in turn affect how well the ...
(Date:7/28/2014)... Hospital study found that 73 percent of adult survivors ... developing metabolic syndrome and related health problems by failing ... the current issue of the journal Cancer . ... of childhood cancer in the study had metabolic syndrome, ... blood pressure, abdominal obesity, elevated triglyceride and other abnormalities ...
(Date:7/28/2014)... powerful new tool that can help advance the ... and renewable bioenergy, has been developed by researchers ... BioEnergy Institute (JBEI), a multi-institutional partnership led by ... researchers have developed an assay that enables scientists ... sugar transporters, critical components in the biosynthesis of ...
Breaking Biology News(10 mins):Strategies identified to improve oral contraceptive success with obese women 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3How sweet it is 2How sweet it is 3
... you enjoy a glass of 100% juice as part of ... factors for several chronic diseases when compared to your non ... (EB) 2009 meeting highlights this association among adult men and ... had better insulin sensitivity and had lower risk for obesity ...
... called "red tide" is expected to be moderately large ... Woods Hole Oceanographic Institution (WHOI) and North Carolina State ... on a regional seafloor survey of quantities of Alexandrium ... accumulates in clams, mussels and other shellfish and that ...
... harassment from males can damage relationships between females is revealed ... the Centre for Research in Animal Behaviour at the University ... Society B , the research uncovers the effect of sexual ... bonds with each other. The study focused on guppies, ...
Cached Biology News:Drinking 100 percent fruit juice is associated with lower risk of obesity and metabolic syndrome 2Marine scientists warn of potential for spring, summer red tide outbreak in Gulf of Maine 2Marine scientists warn of potential for spring, summer red tide outbreak in Gulf of Maine 3Sexual harassment from males prevents female bonding, says study 2
...
...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Biology Products: